Skip to content

Quick ratio at other companies

Schrodinger logo
SchrodingerSDGR
2.7×-0.7×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
5.5×+1.4×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
+0.9×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
13.9×+3.7×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
7.6×-0.7×
ADMA Biologics logo
ADMA BiologicsADMA
3.9×+0.6×

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on the most recent quarter.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's quick ratio?
Absci Corporation (ABSI) reported quick ratio of 6.6× in Q1 2026.
How has Absci Corporation's quick ratio changed year-over-year?
Absci Corporation's quick ratio increased by 15.2% year-over-year, from 5.7× to 6.6×.
What is the long-term trend for Absci Corporation's quick ratio?
Over 5 years (2020 to 2025), Absci Corporation's quick ratio has grown at a -2.0% compound annual growth rate (CAGR), from 7.3× to 6.6×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.